The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome

Neurocase. 2014;20(1):110-20. doi: 10.1080/13554794.2012.732090. Epub 2012 Nov 30.

Abstract

A hexanucleotide repeat expansion in the chromosome 9 open reading frame 72 (C9ORF72) gene was recently discovered as the cause underlying frontotemporal degeneration (FTD) and/or amyotrophic lateral sclerosis (ALS) linked to chromosome 9 (c9FTD/ALS). In this atypical case of c9FTD/ALS, the proband presented with amnestic mild cognitive impairment which evolved into Alzheimer's disease (AD)-type dementia and later developed ALS. Fluorodeoxyglucose-positron emission tomography of the brain demonstrated mild hypometabolism involving the medial frontal and lateral temporal lobes, left more so than right, which progressed over time. He was subsequently confirmed to have the C9ORF72 expansion. This report highlights the need to consider mutations in the FTD-associated genes when a familial disorder is suggested and neuroimaging studies reveal findings atypical of an AD pathophysiological process despite the typical anterograde amnestic syndrome.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / genetics*
  • Amyotrophic Lateral Sclerosis / diagnosis*
  • Amyotrophic Lateral Sclerosis / diagnostic imaging
  • Amyotrophic Lateral Sclerosis / genetics*
  • Brain / pathology
  • C9orf72 Protein
  • Chromosomes, Human, Pair 9
  • DNA Repeat Expansion
  • Disease Progression
  • Fluorodeoxyglucose F18
  • Frontotemporal Dementia / diagnosis*
  • Frontotemporal Dementia / diagnostic imaging
  • Frontotemporal Dementia / genetics*
  • Humans
  • Longitudinal Studies
  • Male
  • Positron-Emission Tomography
  • Proteins / genetics*
  • Radiopharmaceuticals

Substances

  • C9orf72 Protein
  • C9orf72 protein, human
  • Proteins
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18